• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • DMF (Drug Master Filing) – Pharmaceutical Products
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • CML (China Manufacture Licence) – Pressure vessels
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Company Profile
    • Partners
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Information
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • DMF
      • CCC
      • Pressure Vessels
    • Publications
    • Brochure
    • Online Shop
Contact
  • Home
  • News
  • News
  • Medical Devices Listing in Hong Kong
  • Overseas Marketing Approvals for Listing Medical Devices in Hong Kong

Overseas Marketing Approvals for Listing Medical Devices in Hong Kong

Friday, 13 March 2020 / Published in Medical Devices Listing in Hong Kong

Overseas Marketing Approvals for Listing Medical Devices in Hong Kong

On 22.01.2020, the Hong Kong MDD (Medical Device Division) announced the continuance of the pilot phase to study the feasibility for LRP (Local Responsible Persons) to apply the MDACS listing of Class II/III/IV general medical devices in Hong Kong by presenting valid marketing approvals obtained from the China NMPA (National Medical Products Administration). The trial started on 01.06.2018, and will last until 31.12.2020.

Currently, there is also another pilot phase that will last until 31.03.2020 for the MDACS listing of Class II/III/IV general medical devices in Hong Kong by presenting valid marketing approvals obtained from the Ministry of Food and Drug Safety of Korea. Other overseas marketing approvals may also be considered applicable in Hong Kong. Consult us to know more.

On 06.11.2019, the Central Government of PRC has accepted the HKSAR government’s proposal for the use of Hong Kong registered pharmaceutical products and common medical devices in designated Hong Kong-owned medical institutions in the Greater Bay Area.

As a facilitation measure for Hong Kong residents working and living in the Greater Bay Area to seek healthcare services, it will help attract local and multinational pharmaceutical, biomedical and health technology companies to introduce medical devices to Hong Kong with a view to expanding their businesses in Hong Kong and Mainland cities in the Greater Bay Area, benefiting patients in both places.

The Food and Health Bureau will be in discussion with relevant Mainland authorities on the implementation details, including the measure at the University of Hong Kong-Shenzhen Hospital on a pilot basis.

Learn more about how Cisema can support you with the Hong Kong MDACS registration.

Tagged under: Medical Devices

What you can read next

Next Big Step for the Introduction of Hong Kong Medical Devices to the Greater Bay Area
Implementation of Hong Kong-Registered Pharmaceutical Products and Common Medical Devices in China’s Greater Bay Area

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Drug Master Filing
      • Health Food
      • Medical Device
    • RoHS
  • Publications
  • Seminars
  • Webinars

Recent Posts

  • Updates on the Medical Device Classification Catalogue in China

    On December 31, 2020, the NMPA announced (No.14...
  • Cisema Partners with Advamed

    Cisema is delighted to announce it is now an as...
  • Guidelines for Sampling Testing on Organic Foods

    On December 4, 2020, the CNCA (Certification an...
  • Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

    On January 22, 2021, the NIFDC (China National ...
  • Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

    China Regulatory Guidelines Issued / Updated Th...

Archive

Cisema

With nine locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Events
  • News & Information
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2019 Cisema. All rights reserved.

TOP